Wendy S. Putnam

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

Nicola A. Hanania, Phillip E. Korenblat, Kenneth R. Chapman et al. · The Lancet Respiratory Medicine · 2016 · 466 citations

Medicine, Internal Medicine, Pharmacology +10

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

Nicola A. Hanania, Michael Noonan, Jonathan Corren et al. · Thorax · 2015 · 377 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)

Eric L. Simpson, Carsten Flohr, Lawrence F. Eichenfield et al. · Journal of the American Academy of Dermatology · 2018 · 329 citations · Full text

Medicine, Dermatology, Immunology +17

Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids

Michael Noonan, Phillip E. Korenblat, Sofia Mosesova et al. · Journal of Allergy and Clinical Immunology · 2013 · 169 citations

Pharmacy, Pharmacology, Pharmacotherapy +10

Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration

Yanan Zheng, Devin B. Tesar, Lisa J. Benincosa et al. · mAbs · 2012 · 144 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17